STYRENIX Q2 FY27 Guidance vs Delivery (STYRENIX Management Mirror)

Q2 FY27 Consolidated EBITDA Margin Normalises to 7.2%, Meeting the Historical Baseline Guided in Jun'26 Qtr

In Sep'26 Qtr, the company reported a consolidated EBITDA margin of 7.2% in its Quarterly Financial Results, while the standalone EBITDA margin stood at 10.8% according to management commentary. This performance meets the normalization guidance issued in the Jun'26 Qtr concall, where management had cautioned that the prior quarter's inflated margins were a temporary snapshot and explicitly guided investors to model a return to historical operational baselines of around 10% to 12% as price volatility settled. Looking ahead, management expects annualized normalized gross margins and per-kg performance to remain consistent with these historical ranges.